
|Videos|September 26, 2017
Challenges Faced When Creating a Vaccine for HIV
Author(s)Contagion® Editorial Staff
Hanneke Schuitemaker, PhD, explains the challenges faced when creating a vaccine for HIV.
Advertisement
Hanneke Schuitemaker, PhD, Vice President and Head of Viral Vaccines Discovery and Translational Medicine at Janssen Vaccines, explains the challenges faced when creating a vaccine for HIV. Dr. Schuitemaker explains that one of the hardest tasks involves dealing with the "variability of the virus," and since a vaccine for HIV has not been developed yet, researchers are left working through trial-and-error.
Advertisement
Advertisement
Advertisement
Trending on Contagion Live
1
10 Infectious Disease Developments That Defined Q2 2026
2
FDA Grants Priority Review for Dolutegravir in Newborns With HIV
3
Merck, ADAP Crisis Task Force Agree to Expand IDVYNSO Access in HIV
4
HIV in 2026: Four Experts on Aging, Testing, Equity, and Prevention's Next Era
5



























































































































































































